Corcept Therapeutics Inc

GOLDMAN SACHS GROUP INC CORT

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/25/2026

Shares

430,976

Value ($000)

14,998

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/25/2026	14,998	0.0%	430,976	12/31/2025
2025 Q3	11/14/2025	32,337	0.0%	389,086	9/30/2025
2025 Q2	8/14/2025	41,153	0.0%	560,669	6/30/2025
2025 Q1	6/27/2025	57,721	0.0%	505,347	3/31/2025
2024 Q4	2/11/2025	31,557	0.0%	626,246	12/31/2024
2024 Q3	11/14/2024	21,891	0.0%	473,021	9/30/2024
2024 Q2	8/13/2024	15,549	0.0%	478,574	6/30/2024
2024 Q1	5/15/2024	10,951	0.0%	434,722	3/31/2024
2023 Q4	5/14/2024	17,304	0.0%	532,760	12/31/2023
2023 Q3	5/15/2024	11,132	0.0%	408,575	9/30/2023
2023 Q2	5/14/2024	8,083	0.0%	363,267	6/30/2023
2023 Q1	5/14/2024	8,738	0.0%	403,431	3/31/2023
2022 Q4	5/14/2024	9,631	0.0%	474,201	12/31/2022
2022 Q3	5/14/2024	10,820	0.0%	421,993	9/30/2022
2022 Q2	5/14/2024	7,339	0.0%	308,640	6/30/2022
2022 Q1	5/16/2022	7,850	0.0%	348,586	3/31/2022
2021 Q4	2/17/2022	6,956	0.0%	351,346	12/31/2021
2021 Q3	1/20/2022	11,001	0.0%	558,983	9/30/2021
2021 Q2	8/13/2021	8,651	0.0%	393,235	6/30/2021
2021 Q1	5/17/2021	11,515	0.0%	484,016	3/31/2021
2020 Q4	2/12/2021	13,929	0.0%	532,473	12/31/2020
2020 Q3	11/13/2020	8,298	0.0%	476,714	9/30/2020
2020 Q2	8/12/2020	16,160	0.0%	960,711	6/30/2020
2020 Q1	5/15/2020	10,251	0.0%	862,130	3/31/2020
2019 Q4	2/14/2020	5,616	0.0%	464,111	12/31/2019
2014 Q1	5/15/2014	121	0.0%	27,717	3/31/2014
2013 Q4	2/14/2014	70	0.0%	21,775	12/31/2013